{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:15:45Z","timestamp":1707524145543},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,10]]},"DOI":"10.7759\/cureus.10888","type":"journal-article","created":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T18:50:10Z","timestamp":1602355810000},"source":"Crossref","is-referenced-by-count":0,"title":["Posterior Fossa Progressive Multifocal Leukoencephalopathy Secondary to Rituximab"],"prefix":"10.7759","author":[{"given":"Mounika","family":"Guduru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkata Sunil","family":"Bendi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana S","family":"Bebawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh","family":"Bande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Matta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2011.11.002","article-title":"Progressive multifocal leukoencephalopathy in autoimmune diseases","volume":"79","author":"Palazzo E","year":"2012","unstructured":"Palazzo E, Yahia SA. Progressive multifocal leukoencephalopathy in autoimmune diseases. Joint Bone Spine. 2012, 79:351-355. 10.1016\/j.jbspin.2011.11.002","journal-title":"Joint Bone Spine"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/1756285615602832","article-title":"Progressive multifocal leukoencephalopathy: current treatment options and future perspectives","volume":"8","author":"Pavlovic D","year":"2015","unstructured":"Pavlovic D, Patera AC, Nyberg F, Gerber M, Liu M. Progressive multifocal leukoencephalopathy: current treatment options and future perspectives. Ther Adv Neurol Disord. 2015, 8:255-273. 10.1177\/1756285615602832","journal-title":"Ther Adv Neurol Disord"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904267","article-title":"Asymptomatic reactivation of JC virus in patients treated with natalizumab","volume":"361","author":"Chen Y","year":"2009","unstructured":"Chen Y, Bord E, Tompkins T,e t al. Asymptomatic reactivation of JC virus in patients treated with natalizumab. N Engl J Med. 2009, 361:1067-1074. 10.1056\/NEJMoa0904267","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2018.06.002","article-title":"Progressive multifocal leukoencephalopathy","volume":"36","author":"Grebenciucova E","year":"2018","unstructured":"Grebenciucova E, Berger JR. Progressive multifocal leukoencephalopathy. Neurol Clin. 2018, 36:739-750. 10.1016\/j.ncl.2018.06.002","journal-title":"Neurol Clin"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.11477\/mf.1416200228","article-title":"[Neuropathology of natalizumab-associated progressive multifocal leukoencephalopathy]","volume":"67","author":"Kanda T","year":"2015","unstructured":"Kanda T. [Neuropathology of natalizumab-associated progressive multifocal leukoencephalopathy]. Brain Nerve. 2015, 67:891-901. 10.11477\/mf.1416200228","journal-title":"Brain Nerve"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/1073274817729901","article-title":"Progressive multifocal leukoencephalopathy and monoclonal antibodies: a review","volume":"24","author":"Bohra C","year":"2017","unstructured":"Bohra C, Sokol L, Dalia S. Progressive multifocal leukoencephalopathy and monoclonal antibodies: a review. Cancer Control. 2017, 24:1073274817729901. 10.1177\/1073274817729901","journal-title":"Cancer Control"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.103","article-title":"Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis","volume":"68","author":"Clifford DB","year":"2011","unstructured":"Clifford DB, Ances B, Costello C, et al.. Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis. Arch Neurol. 2011, 68:1156-1164. 10.1001\/archneurol.2011.103","journal-title":"Arch Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2010.01.002","article-title":"Rituximab-associated infections","volume":"47","author":"Gea-Banacloche JC","year":"2010","unstructured":"Gea-Banacloche JC. Rituximab-associated infections. Semin Hematol. 2010, 47:187-198. 10.1053\/j.seminhematol.2010.01.002","journal-title":"Semin Hematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2017.10.007","article-title":"Neuromyelitis optica spectrum disorders in Iran","volume":"18","author":"Eskandarieh S","year":"2017","unstructured":"Eskandarieh S, Nedjat S, Azimi AR, Moghadasi AN, Sahraian MA. Neuromyelitis optica spectrum disorders in Iran. Mult Scler Relat Disord. 2017, 18:209-212. 10.1016\/j.msard.2017.10.007","journal-title":"Mult Scler Relat Disord"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2010.03.001","article-title":"Imaging manifestations of progressive multifocal leukoencephalopathy","volume":"65","author":"Shah R","year":"2010","unstructured":"Shah R, Bag AK, Chapman PR, Cur\u00e9 JK. Imaging manifestations of progressive multifocal leukoencephalopathy. Clin Radiol. 2010, 65:431-439. 10.1016\/j.crad.2010.03.001","journal-title":"Clin Radiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-186999","article-title":"Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project","volume":"113","author":"Carson KR","year":"2009","unstructured":"Carson KR, Evens AM, Richey EA, et al.. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood. 2009, 113:4834-4840. 10.1182\/blood-2008-10-186999","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-120329","article-title":"The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34 hematopoietic progenitor cells in humans","volume":"111","author":"Zohren F","year":"2008","unstructured":"Zohren F, Toutzaris D, Kl\u00e4rner V, Hartung HP, Kieseier B, Haas R. The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34 hematopoietic progenitor cells in humans. Blood. 2008, 111:3893-3895. 10.1182\/blood-2007-10-120329","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/nm0303-269","article-title":"Immunotherapy: past, present and future","volume":"9","author":"Waldmann TA","year":"2003","unstructured":"Waldmann TA. Immunotherapy: past, present and future. Nat Med. 2003, 9:269-277. 10.1038\/nm0303-269","journal-title":"Nat Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/22347-posterior-fossa-progressive-multifocal-leukoencephalopathy-secondary-to-rituximab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:18:32Z","timestamp":1707506312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/22347-posterior-fossa-progressive-multifocal-leukoencephalopathy-secondary-to-rituximab"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,10]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.10888","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,10]]}}}